Sponsor:
National Cancer Institute (NCI)
Code:
NCT05669664
Conditions
Locally Advanced Salivary Gland Carcinoma
Metastatic Salivary Gland Carcinoma
Recurrent Salivary Gland Carcinoma
Unresectable Salivary Gland Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy Procedure
Biospecimen Collection
Computed Tomography
Darolutamide
Leuprolide Acetate
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2025-05-28.